Published in J Immunol on November 15, 1996
Leishmaniasis: current status of vaccine development. Clin Microbiol Rev (2001) 2.62
SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol (2001) 1.68
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun (2003) 1.38
Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model. PLoS Negl Trop Dis (2007) 1.16
Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun (2007) 1.14
Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice. Infect Immun (2000) 1.12
Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics (2003) 1.05
Development of Vaccines against Visceral Leishmaniasis. J Trop Med (2011) 1.03
In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection. BMC Microbiol (2001) 1.03
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis. Clin Vaccine Immunol (2011) 1.01
Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect Immun (2000) 0.97
Regulation of immunity during visceral Leishmania infection. Parasit Vectors (2016) 0.92
Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs. Infect Immun (2002) 0.91
Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasit Vectors (2011) 0.91
The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum. Infect Immun (2003) 0.85
Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver. Infect Immun (2010) 0.82
Natural killer cells in experimental and human leishmaniasis. Front Cell Infect Microbiol (2012) 0.82
Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity. Antimicrob Agents Chemother (2009) 0.79
Study of Leishmania pathogenesis in mice: experimental considerations. Parasit Vectors (2016) 0.77
Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection. Parasit Vectors (2015) 0.75
Redundant and regulatory roles for TLRs in Leishmania infection. Clin Exp Immunol (2017) 0.75
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Malaria pathogenesis. Science (1994) 4.76
Pleiotropic control of Listeria monocytogenes virulence factors by a gene that is autoregulated. Mol Microbiol (1991) 3.73
A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol (2000) 3.47
Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science (2000) 2.92
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med (1998) 2.30
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci U S A (2007) 2.14
An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol (2000) 2.11
Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host. Cell Microbiol (2001) 1.81
Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J Immunol Methods (1990) 1.76
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol (2001) 1.72
Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J (1994) 1.70
T-cell responses and immunity to experimental infection with leishmania major. Annu Rev Immunol (1989) 1.68
Titration and circulation of cells mediating delayed type hypersensitivity in normal and cyclophosphamide treated mice during response to sheep red blood cells. Immunology (1978) 1.64
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Autoimmune response to DNA, red blood cells, and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis. J Immunol (1979) 1.60
Molecular characterisation of ninein, a new coiled-coil protein of the centrosome. J Cell Sci (1996) 1.59
TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw (1994) 1.56
Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol (1987) 1.46
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. J Immunol (1986) 1.45
Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45
The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol (2001) 1.40
Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J Immunol (1997) 1.39
Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo. J Exp Med (1989) 1.38
Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol (2000) 1.36
Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells. Int Immunol (1991) 1.35
Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology (1998) 1.33
A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J Immunol Methods (1996) 1.32
Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int Immunol (1995) 1.30
Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization. J Exp Med (1991) 1.28
Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience (1991) 1.26
Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment. Immunology (1978) 1.26
Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol (1982) 1.25
Dynamics of lymphocytes and inflammatory cells recruited in liver during murine listeriosis. A cytofluorimetric study. J Immunol (1991) 1.21
Fate of antigen-binding cells in unresponsive and immune mice. J Exp Med (1973) 1.20
L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur J Immunol (1987) 1.20
Recognition of protozoan parasite antigens by murine T lymphocytes. I. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica. Eur J Immunol (1979) 1.20
Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol (2000) 1.19
Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major. Infect Immun (1994) 1.19
Induction of protective CD8+ T lymphocytes by an attenuated Listeria monocytogenes actA mutant. Int Immunol (1992) 1.15
Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunol (1987) 1.12
Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice. Infect Immun (2000) 1.12
Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major. Immunol Rev (1989) 1.12
Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s). Eur J Immunol (1984) 1.09
Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp Parasitol (1992) 1.08
Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice. J Immunol (1983) 1.07
Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann Trop Med Parasitol (1995) 1.07
Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3. Eur J Immunol (1988) 1.05
Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen. Proc Natl Acad Sci U S A (1996) 1.05
The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol (1998) 1.05
In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania. Eur J Immunol (1989) 1.04
Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr (1995) 1.04
Mathematical model for the control of nosocomial norovirus. J Hosp Infect (2009) 1.03
Interaction between cyclosporin and erythromycin in a kidney transplant patient. Eur J Clin Pharmacol (1986) 1.02
Differential nucleolar staining affinity with a modified Papanicolaou staining procedure. Stain Technol (1981) 1.01
Induction of thymocytotoxic autoantibodies after injection of bacterial lipopolysaccharides in mice. Eur J Immunol (1979) 1.00
Biocide gene(s) and biocidal activity in different strains of Bacillus sphaericus. Expression of the gene(s) in E. coli maxicells. Mol Gen Genet (1984) 1.00
Control of hemopoiesis in mice by sensitized L3T4+ Lyt2-lymphocytes during infection with bacillus Calmette-Guérin. Proc Natl Acad Sci U S A (1986) 0.99
Plasticity of T reg at infected sites. Mucosal Immunol (2010) 0.98
Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J Immunol Methods (1997) 0.98
Fertile dominant spotting in the house mouse. J Hered (1979) 0.98
Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage. Eur J Immunol (1997) 0.97
A variational approach to the radiometric enhancement of digital imagery. IEEE Trans Image Process (1995) 0.96
Permissiveness of human monocytes and monocyte-derived macrophages to infection by promastigotes of Leishmania (Viannia) panamensis. J Parasitol (1998) 0.96
Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells? J Immunol (1983) 0.95
Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection. Clin Exp Immunol (1981) 0.95
Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB/c mice: localization and characterization. Cell Microbiol (2000) 0.94
Frequency and cross-reactivity od cytolytic T lymphocyte precursors reacting against male alloantigens. J Immunol (1982) 0.93
The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology (1997) 0.93
Abnormal organisation of the splenic marginal zone and the correlated leukocytosis in lymphotoxin-alpha and tumor necrosis factor alpha double deficient mice. Eur Cytokine Netw (1996) 0.93
Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol (2012) 0.93
Apparent increased sensitivity of mice to tuberculin by adding a non-specific inflammatory agent to the antigen. Tubercle (1986) 0.93
BCG-induced anaemia in mice: no direct effect of the growth of bacilli. Ann Immunol (Paris) (1984) 0.92
Specific Schistosoma mansoni rat T cell clones. I. Generation and functional analysis in vitro and in vivo. J Immunol (1985) 0.92
Transfer of both protection and delayed-type hypersensitivity against live Listeria is mediated by the CD8+ T cell subset: a study with Listeria-specific T lymphocytes recovered from murine infected liver. Int Immunol (1992) 0.91
A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo. Eur J Immunol (1990) 0.91
The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab (2009) 0.91
Narcolepsy in children. Sleep (1994) 0.90
Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major. Infect Immun (2000) 0.90
[In vitro sensitivity of Yersinia pestis to some antibiotics and sulfonamides]. Med Trop (Mars) (1969) 0.89
Cyclophosphamide therapy in acute leukemia of childhood. Cooperative study conducted by members of Children's Cancer Cooperative Group A. Cancer (1966) 0.89
Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCG. Scand J Immunol (2002) 0.89
Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice. Proc Natl Acad Sci U S A (1995) 0.88
Nephrotoxicity of orellanine, a toxin from the mushroom Cortinarius orellanus. Arch Toxicol (1988) 0.88
Decreased erythropoiesis: the origin of the BCG induced anaemia in mice. Br J Haematol (1981) 0.88
Mouse mammary tumor virus superantigens and murine autoimmune gastritis. Gastroenterology (1994) 0.87
Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG. Res Immunol (1993) 0.86
New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice. Microbes Infect (1999) 0.86
Numeration of DTH-mediating T lymphocytes in mice under optimal titration conditions. Ann Immunol (Paris) (1984) 0.86